← All organizations

Cour Pharmaceutical Development Company, Inc.

For profitWebsite ↗

Also known as: Cour Pharmaceutical Development Company, Inc. | COUR Pharmaceutical Development Company, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 12, 2025

Timeline

2010s

Jun 1, 2012
Cour Pharmaceutical Development Company, Inc.— Founded

Drugs by trial phase (5 distinct, 7 trials)

Phase 2 (5 own, 0 via acquisition)

Indications

Studied for

Celiac Disease

Recent trials (7)

NCT06783309Lead sponsorPhase 1/Phase 2May 12, 2025
NCT06106672Lead sponsorPhase 1/Phase 2Jan 31, 2024
NCT05250856Lead sponsorPhase 1/Phase 2Mar 14, 2022
NCT05104853Lead sponsorPhase 1/Phase 2Dec 1, 2021
NCT04950504Lead sponsorPhase 1/Phase 2Jun 2, 2021
NCT03738475Lead sponsorPhase 2Jan 4, 2019
NCT03486990Lead sponsorPhase 1Feb 9, 2018

Details

Founded: Northbrook, IL, US Jun 1, 2012
Last known activity: May 12, 2025